The data is impossible to ignore. According to the 2024 Quest Diagnostics Drug Testing Index, the rate of substituted urine specimens i...
The drug testing landscape is experiencing its most significant shift in decades, and it's driven by a single, alarming number: a 600% ...
Chain-of-custody challenges remain the number one tactic used in drug testing litigation. According to legal case analyses from 2023-20...
When an employee shows signs of a substance use disorder, managers often feel trapped between two difficult choices: immediate terminat...
Post-accident drug test positivity rates now sit at 10.4%, a stark contrast to the 2.9% found in standard random testing programs. This...
The most common FMCSA violation isn't a failed drug test. It's a missing document. Simple recordkeeping gaps, like an expired random po...
Random employee drug tests in 2024 revealed fentanyl positivity rates 707% higher than in pre-employment screens. This jarring s...
A single non-compliance violation in your drug testing program can trigger a federal fine of up to $145,027. This isn't just a risk for...
The rate of post-accident marijuana positivity has hit a staggering 7.3%. According to the 2025 Quest Diagnostics Drug Testing Index, t...
A common belief among employers and clinicians is that a standard drug test panel provides a comprehensive safety net. The reality is s...
Legalizing fentanyl test strips is associated with a 7% decrease in overdose mortality, a figure that jumps to 13.5% among Black indivi...
Data from the 2025 Quest Diagnostics Drug Testing Index reveals a startling gap in workplace safety: Fentanyl positivity in random drug...
